Tejas P Joshi Sara Anvari Meera R Gupta Carla M Davis Joud Hajjar
10.3389/fped.2021.646997
Front Pediatr
2021 Sep 29;9:646997.
dupilumab hyper-ige syndrome pediatrics-children primary immunodeficencies severe eczema
CC BY
https://pubmed.ncbi.nlm.nih.gov/34660469/
Case Reports
PMC8511520
34660469
Case Report: Dupilumab Successfully Controls Severe Eczema in a Child With Elevated IgE Levels and Recurrent Skin Infections
2021